Association of a single nucleotide polymorphism in the TIGR/MYOCILIN gene promoter with the severity of primary open-angle glaucoma
Authors: Colomb, E1; Nguyen, TD2; Béchetoille, A3; Dascotte, J-C4; Valtot, F5; Brézin, AP6; Berkani, M7; Copin, B1; Gomez, L1; Polansky, JR2; Garchon, H-J1
Source: Clinical Genetics, Volume 60, Number 3, September 2001 , pp. 220-225(6)
Publisher: Blackwell Publishing
Abstract:
Primary open-angle glaucoma (POAG) is a highly prevalent optic neuropathy and a major cause of irreversible blindness, with elevation of intraocular pressure (IOP) being a primary risk factor. The trabecular meshwork-inducible glucocorticoid response (TIGR)/MYOCILIN (MYOC) gene coding region is mutated in 3-4% of POAG patients. Here, in a retrospective study of 142 POAG patients, we evaluated the influence on glaucoma phenotype of a novel biallelic polymorphism (−1000C/G) located in the upstream region of the MYOC gene. Allele frequencies were similar among patients and controls. However, the G allele (frequency 17.6%), also designated as MYOC.mt1, was associated with an increased IOP (+4.9 mmHg, p=0.0004) and a more damaged visual field (p=0.02). Both effects were predominant in females. Moreover, whereas IOP in MYOC.mt1 noncarriers decreased very markedly to the normal range between diagnosis and inclusion in the study (p=3×10−5 in both males and females), reflecting successful therapy, it decreased less noticeably in MYOC.mt1+ male patients (p=0.005) and not at all in MYOC.mt1+ female patients. MYOC.mt1 appears therefore to be an indicator of poor IOP control and greater visual field damage in diagnosed POAG patients, potentially due to a lack of response to therapeutic intervention. Its typing might help in the selection of treatment paradigms for the management of POAG patients.Keywords: genetics; glaucoma; myocilin; ocular hypertension; promoter; single nucleotide polymorphism
Document Type: Research article
DOI: 10.1034/j.1399-0004.2001.600308.x
Affiliations: 1: INSERM U25, Paris, France; 2: Department of Ophthalmology, University of California at San Francisco, CA, USA; 3: Service d'ophtalmologie, CHU Angers, Angers, 4: Service d'ophtalmologie, CHU Lille, Lille, 5: CHNO Quinze-vingts, 6: Service d'ophtalmologie, CHU Cochin, 7: Institut du Glaucome, Hôpital Saint-Joseph, Paris, France

Click here for Page Help